Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Second Sight Medical Products is a medical technology company dedicated to developing implantable visual prosthetics to restore functional vision to blind individuals. The company is best known for the Argus II Retinal Prosthesis System, the first FDA-approved "bionic eye" for patients with severe to profound retinitis pigmentosa. Following a period of financial restructuring and a merger with Nano Precision Medical in 2022, the company transitioned its focus toward the Orion Visual Cortical Prosthesis System, which bypasses the optic nerve to stimulate the brain directly. Now operating as part of Vivani Medical, the technology continues to represent a frontier in neuromodulation and sensory restoration.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Second Sight Solutions.